Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Metastatic Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04134312
What this trial is testing

Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

Who this might be right for
Solid Metastatic Tumor
Bavarian Nordic 13
Large-scale testing (Phase 3)Study completedNCT01372774
What this trial is testing

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerNeurotoxicity+2 more
Alliance for Clinical Trials in Oncology 194
Early research (Phase 1)Study completedNCT00692159
What this trial is testing

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

Who this might be right for
Neoplasm
Tracon Pharmaceuticals Inc. 28
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Early research (Phase 1)Study completedNCT02219724
What this trial is testing

Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 174
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Study completedNCT00635778
What this trial is testing

A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06926751
What this trial is testing

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Who this might be right for
Solid TumorsChildrenAdolescent+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 132
Early research (Phase 1)Looking for participantsNCT06410131
What this trial is testing

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

Who this might be right for
Solid Tumors
Sound Biopharmaceuticals Ltd. 68
Early research (Phase 1)Study completedNCT02004548
What this trial is testing

Phase I Clinical Study of Metatinib Tromethamine Tablet

Who this might be right for
Advanced or Metastatic Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00741260
What this trial is testing

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT04041310
What this trial is testing

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Who this might be right for
Solid Tumor, Adult
Nouscom SRL 115
Testing effectiveness (Phase 2)Looking for participantsNCT05222620
What this trial is testing

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Mayo Clinic 90
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Not applicableActive Not RecruitingNCT05863052
What this trial is testing

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Who this might be right for
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more
University of Oklahoma 72
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Early research (Phase 1)Active Not RecruitingNCT05378425
What this trial is testing

NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+2 more
Nectin Therapeutics Ltd 90
Early research (Phase 1)Study completedNCT04678921
What this trial is testing

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid TumorMetastatic CancerAdvanced Cancer
I-Mab Biopharma US Limited 16
Next Page
150